SIMONE, Isabella Laura
 Distribuzione geografica
Continente #
NA - Nord America 11.966
AS - Asia 4.540
EU - Europa 2.783
SA - Sud America 1.118
AF - Africa 142
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 8
Totale 20.570
Nazione #
US - Stati Uniti d'America 11.849
SG - Singapore 1.770
HK - Hong Kong 1.062
CN - Cina 1.052
BR - Brasile 974
SE - Svezia 533
IT - Italia 417
DE - Germania 386
RU - Federazione Russa 386
UA - Ucraina 340
VN - Vietnam 257
FI - Finlandia 223
GB - Regno Unito 192
IN - India 92
FR - Francia 90
CI - Costa d'Avorio 68
CA - Canada 61
AR - Argentina 57
BD - Bangladesh 51
IQ - Iraq 40
BE - Belgio 37
ID - Indonesia 37
MX - Messico 31
IE - Irlanda 29
ZA - Sudafrica 29
PL - Polonia 28
EC - Ecuador 25
JP - Giappone 24
TR - Turchia 24
AT - Austria 23
ES - Italia 22
NL - Olanda 20
AE - Emirati Arabi Uniti 19
UZ - Uzbekistan 19
LT - Lituania 16
UY - Uruguay 14
VE - Venezuela 13
JO - Giordania 11
MA - Marocco 11
PK - Pakistan 10
SA - Arabia Saudita 10
CO - Colombia 9
PY - Paraguay 8
AZ - Azerbaigian 7
EU - Europa 7
KE - Kenya 7
MY - Malesia 7
PE - Perù 7
AU - Australia 6
BG - Bulgaria 6
EG - Egitto 6
IL - Israele 6
IR - Iran 6
BO - Bolivia 5
CL - Cile 5
CW - ???statistics.table.value.countryCode.CW??? 5
JM - Giamaica 5
OM - Oman 5
RO - Romania 5
TN - Tunisia 5
BY - Bielorussia 4
CR - Costa Rica 4
GE - Georgia 4
KR - Corea 4
LV - Lettonia 4
NP - Nepal 4
TW - Taiwan 4
BH - Bahrain 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
KZ - Kazakistan 3
NI - Nicaragua 3
PT - Portogallo 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AL - Albania 2
AO - Angola 2
BB - Barbados 2
EE - Estonia 2
ET - Etiopia 2
GA - Gabon 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
MK - Macedonia 2
CH - Svizzera 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
GT - Guatemala 1
GY - Guiana 1
KG - Kirghizistan 1
LC - Santa Lucia 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
MR - Mauritania 1
NG - Nigeria 1
Totale 20.558
Città #
Fairfield 1.523
Woodbridge 1.170
Ashburn 1.075
Singapore 908
Chandler 901
Houston 797
Jacksonville 783
Seattle 635
Hong Kong 589
Wilmington 558
Cambridge 529
Ann Arbor 487
Nyköping 369
Beijing 271
Roxbury 224
Lawrence 223
New York 194
Nanjing 179
Boardman 154
Des Moines 149
Los Angeles 107
Dallas 100
Bari 96
Princeton 93
Ho Chi Minh City 87
San Diego 75
Abidjan 68
Santa Clara 64
São Paulo 64
Brooklyn 63
Nanchang 63
Munich 61
Inglewood 60
Hebei 55
Dearborn 51
Jiaxing 50
Shenyang 48
Buffalo 46
Hanoi 45
London 45
Tianjin 39
Falls Church 38
Brussels 37
Rio de Janeiro 37
Dong Ket 36
Belo Horizonte 34
Council Bluffs 33
Paris 31
Marseille 30
Dublin 29
Changsha 28
Norwalk 28
Jakarta 27
Moscow 25
Redwood City 24
Guangzhou 23
Pune 22
Tokyo 22
Warsaw 21
Nuremberg 20
Columbus 19
The Dalles 19
Curitiba 18
Helsinki 18
Brasília 17
Frankfurt am Main 17
Tashkent 17
Turin 17
Boston 16
San Francisco 16
Johannesburg 15
Milan 15
Shanghai 15
Stockholm 15
Taranto 15
Baghdad 14
Chennai 14
Chicago 14
Rome 14
Campinas 13
San Jose 13
Washington 13
Jinan 12
Montreal 12
San Mateo 12
Toronto 12
Atlanta 11
Denver 11
Indiana 11
Kunming 11
Leawood 11
Zhengzhou 11
Amman 10
Amsterdam 10
Auburn Hills 10
Haiphong 10
Monmouth Junction 10
Phoenix 10
Quito 10
Ribeirão Preto 10
Totale 14.181
Nome #
Adherence to riluzole in patients with amyotrophic lateral sclerosis: An observational study 642
Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis 194
Corrigendum: Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis 191
Assisting persons with advanced amyotrophic lateral sclerosis in their leisure engagement and communication needs with a basic technology-aided program 166
Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study 164
Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis 163
Episodic memory and learning rates in amyotrophic lateral sclerosis without dementia 161
Convexal subarachnoid hemorrhage and acute ischemic stroke: a border zone matter? 160
Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: A retrospective observational study 159
A rare association between multiple sclerosis and Charcot-Marie-Tooth type 1B 157
Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis 146
Pseudobulbar affect as a negative prognostic indicator in amyotrophic lateral sclerosis 143
Nutritional prognostic factors for survival in amyotrophic lateral sclerosis patients undergone percutaneous endoscopic gastrostomy placement 141
IMMUNOPATOLOGIA DELLA SCLEROSI MULTIPLA 135
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 135
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis 134
Multiparametric unconventional MRI study in early stage of ALS disease 131
A Novel CSF1R Mutation in a Patient with Clinical and Neuroradiological Features of Hereditary Diffuse Leukoencephalopathy with Axonal Spheroids 130
Double-Blind Placebo-Controlled Trial on the Use of Acetyl-L-Carnitine for the Treatment of Amyotrophic Lateral Sclerosis (P04.151) 128
Analisi longitudinale dei livelli sierici di ICAM-1 solubile e dei subsets di linfociti T in pazienti con Sclerosi Multipla a decorso remittente in trattamento con IFNb-1b 128
Hirayama disease: the importance of an early diagnosis 123
Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis 123
Intrathecal immune response in human immunodeficiency virus infection 122
ALS multidisciplinary clinic and survival. Results from a population-based study in Southern Italy 122
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry 122
The role of imaging in Hirayama disease 122
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients 121
MR evaluation of encephalic leukoaraiosis in sudden sensorineural hearing loss (SSNHL) patients 120
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. 119
Long term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experience 113
Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study 113
HFE p.H63D polymorphism does not influence ALS phenotype and survival 113
Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study 111
1H-MR Spectroscopy profiles in normal appearing white matter(NAWM) of clinically isolated sindromes suggestive of multiple sclerosis(CIS) 111
Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial) 109
Cerebrospinal Fluid and Clinical Profiles in Adult Type 2–3 Spinal Muscular Atrophy Patients Treated with Nusinersen: An 18-Month Single-Centre Experience 107
Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled,multicentre clinical trial for colchicine in ALS (Co-ALS) 106
Brain cortex thinning in motor and extra-motor areas in amyotrophic lateral sclerosis 105
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study. 105
1H-MRSA comparison of normal appearing white matter in different clinical MS subgroups 104
Trauma and amyotrophic lateral sclerosis: a case-control study from a population-based registry. 103
Brain Cortex Thinning in Motor And Extra-motor Areas in Amyotrophyc Lateral Sclerosis 101
null 101
null 100
Verbal Learning Abilities in ALS Patients (P01.109) 100
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 99
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 99
High resolution proton MR-spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques 98
Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances 98
Elevated plasma homocystein levels in patients with Amyotrophic lteral sclerosis 97
Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG. 97
Motor-evoked potentials in amyotrophic lateral sclerosis: potential implications in detecting subclinical UMN involvement in lower motor neuron phenotype 97
N-Acetyl-Aspartate (NAA) and Neurofilament-Light Chain (NF-L) in biological fluids as markers of neurodegeneration in ALS 96
Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues 96
The importance of maintaining the same order of performance of lung function and SNIP tests in patients with amyotrophic lateral sclerosis 96
Analysis of shared common genetic risk between amyotrophic lateral sclerosis and epilepsy 96
null 95
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients 94
Incidence of amyotrophic lateral sclerosis in Europe 93
G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial) 93
BRAIN CORTEX THINNING IN MOTOR AND EXTRA-MOTOR AREAS IN AMYOTROPHIC LATERAL SCLEROSIS 91
Prognostic factors in ALS: A critical review 90
99mTc-HM-PAO SPET and proton magnetic resonance spectroscopy in patients with ischaemic cerebral infarction 89
Cerebrospinal Fluid and Serum Neurofilament Light Chain Levels in ALS Patients 89
Intra blood-barrier (BBB) immune rersponse in HIV-infected patients 88
null 88
Life-threatening ADEM in an immunocompetent pregnant woman with concomitant asymptomatic Cytomegalovirus infection 88
Alzheimer disease: comparison of 99mTc-HMPAO SPET and 1H-MRS data 87
Is cerebrospinal fluid amyloid-β42 a promising biomarker of response to nusinersen in adult spinal muscular atrophy patients? 86
null 85
null 84
Benign and malignant MS:clinical and 1H-MRS parameters associated with different MS courses 83
null 83
A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD 83
Relationships between regional cortical atrophy and cognitive dysfunction in non-demented ALS patients 82
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. 82
A novel KIF5A mutation in an Italian family marked by spastic paraparesis and congenital deafness 82
dentification of a point mutation impairing the binding between Aquaporin-4 and the Neuromyelitis Optica autoantibodies 81
99Tcm-HMPAO SPET and 1H-MRS (Proton Magnetic Resonance Spectroscopy) in patients with ischaemic cerebral infarction 81
The contribution of (1)H-magnetic resonance spectroscopy in defining the pathophysiology of multiple sclerosis. 79
A 71-nucleotide deletion in the periaxin gene in an Italian patient with late-onset slowly progressive demyelinating CMT 79
null 78
null 78
null 78
null 78
Inclusion of motor evoked abnormalities in amyotrophic lateral sclerosis: a diagnostic algorithm to early classify lower motor neuron phenotypes 78
Whole-brain and regional brain atrophy in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol. 2007 Feb;28(2):255-9 77
null 77
null 77
N-Acetyl-Aspartate (NAA) and Neurofilament Light-Chain (NF-L) in Biological Fluids as Markers of Neurodegeneration in ALS 76
Brain cortical thinning in Motor and Extra-motor areas in Amyotrophic Lateral Sclerosis 76
Is Frontal Assessment Battery a useful instrument to detect cognitive impairment in ALS?. 76
Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy 76
null 75
Sintesi intratecale di IgG in corso di infezioni da HIV 75
null 75
null 75
null 75
Pseudobulbar affect (PBA) in an incident ALS cohort: results from the Apulia registry (SLAP). 74
null 74
Totale 10.976
Categoria #
all - tutte 88.336
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.336


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.531 0 0 0 0 0 220 250 169 230 314 190 158
2021/20221.878 55 78 16 37 82 172 46 72 99 110 262 849
2022/20232.261 365 220 157 211 293 255 32 249 393 14 40 32
2023/2024809 57 153 51 39 54 232 21 34 18 21 5 124
2024/20253.356 107 65 322 119 88 285 207 274 173 194 491 1.031
2025/20263.484 1.070 279 410 718 660 347 0 0 0 0 0 0
Totale 21.367